THT Biomaterials

Founded

2020

Staff

1

Organization type

RDM biotech/pharma

Cluster

LISAvienna

Translation and Reproducibility - Standardized HUMAN Biomaterials: THT Biomaterials GmbH aims to overcome major methodological issues at the bottom of today’s drug development, tissue engineering and regenerative medicine research practices leading to false positive or negative results. A new visionary platform technology is under development that will speed up research as it makes its results more realistic by replacing animal components with human components.

R&D:We use human-derived proteins and other biomaterials, to humanize cell culture in various research fields, comprising 2D and 3D applications such as coatings, gels or tissue-inks. Moreover, human biomaterials are in favour when compared to biomaterials from other species in humans such as (wound)filler, implants, haemostats, long-time-drug-deliveries, and many other applications.